According to a market research report by Roots Analysis, quantum computing in drug discovery services market is predicted to grow at a CAGR of 14% by 2035

Stakeholders in the biopharmaceutical industry are currently exploring the implementation of quantum computing to accelerate drug development and reduce overall R&D investment.

LONDON, September 6, 2023 /PRNewswire/ — Root analysis announced additional “Quantum computer market in drug discovery, 2023-2035” reports a list of its services.

Owing to the various benefits of quantum computing, such as big data processing and complex molecular modeling to minimize costs and time investment, the adoption rate of quantum computing in the pharmaceutical industry is expected will increase rapidly during the forecast period. Additionally, various partnerships have been signed to apply quantum computing to drug discovery. The majority of these partnerships are research and development agreements followed by platform usage agreements. Drug developers need support from both quantum computing hardware and software developers. IN July 2021Riverlane and Astex Pharmaceuticals announced their collaboration with Rigetti Computing to use their quantum system along with Riverlane’s algorithmic expertise to develop molecular models of chemical compounds and study the their interactions with proteins in the human body.

To order this 170+ slide report, which includes 30+ figures and 75+ tables, please visit our Quantum Computing Market Report

Key market insights

• Currently, more than 45 companies globally claim to provide quantum computing services across different steps of drug discovery
• Leveraging their expertise, 86% of stakeholders provide such services in discovery/targeting, primarily focused on cancer disorders
• To gain a competitive edge, the manufacturers claim to continuously expand their existing capabilities to enhance their portfolio of services related to quantum computing
• Sponsorships are more valuable 70 million USD has been awarded to various organizations that have actively undertaken R&D efforts to evaluate the potential of quantum computing in drug discovery
• A significant increase in collaborative activity has been seen over the past few years; Nearly 50% of the collaborations are carried out by companies based in the same region
• More than 30 players worldwide claim to provide hardware services for quantum computing in drug discovery and have developed the necessary expertise in different types of computational methods
• The majority of quantum computing hardware vendors are based in North America, established before 2000; in fact, ~50% of the total market landscape is served by large companies.
• Increased adoption of quantum computing in the biopharmaceutical industry is predicted to create lucrative business opportunities for both software and hardware vendors
• Based on the pioneer-migrant-settlement map, we have classified software vendors into different types; The selection of pioneers is expected to provide valuable services to lead the market in the long term
• We expect the market to grow at an annual rate of 14% over the next decade; Opportunities can be well distributed across drug discovery service types, therapeutic areas and key geographies

The story continues

For more details, please visit

https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html

The financial opportunity in the quantum computing drug discovery services market has been analyzed across the following segments:

The study also includes detailed profiles of key players (are listed below) participates in quantum computing in the drug discovery services market; Each profile has general information about the company, financial information of the company (if any), detailed information regarding the service portfolio as well as recent developments and well-informed future prospects.

• Accenture
• Amazon Web Services
• atom
• Fujitsu
• Huawei
• IBM
• Microsoft
• The cage
• XtalPi

Key questions answered

• What is quantum computing and how does it work in drug discovery?
• What is the current market landscape of the quantum computing market focused on drug discovery?
• What are the major trends in grants awarded to quantum computing in drug discovery?
• What are the key trends in partnerships and collaborations for quantum computing in drug discovery?
• What is the impact of quantum computing on the pharmaceutical industry?
• What is the market size of quantum computing in the drug discovery services market?
• Who are the players in the drug discovery services market in quantum computing?

Table of contents

1. Preface
2. Executive summary
3. Introduce
4. Market Context: Software Vendors
5. Analyze the company’s competitiveness
6. Company profile: Software provider
7. Market context: Hardware vendors
8. Company profile: Hardware supplier
9. Study funding analysis
10. Partnership and cooperation
11. Use case studies
12. Porter’s five forces analysis
13. Blue ocean strategy
14. Analyze market size and opportunities
15. Deep understanding of operations
16. Appendix I- Tabulated data
17. Appendix II- List of companies

You may also be interested in the following titles:

1. Blockchain technology in the healthcare market, 2023-2035
2. Digital therapeutics market, 2023-2035
3. Digital Twin Market, 2022-2035

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-quantum-computing-in-drug-discovery-services-market-is-anticipated-to-grow-at -14-cagr -by-2035-according-to-a-market-research-report-by-roots-analysis-301916995.html

SOURCE Root Analysis